ROCKVILLE, Md., April 20, 2022 (GLOBE NEWSWIRE) — OPGN, ", OpGen", ))))), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today that its subsidiary, Ares Genetics ("Ares"), which strives to become a leader in bacterial genomics and AI-powered prediction of antimicrobial resistance (AMR), is commercially launching a series of new genome sequencing and analysis services globally.
Grid Dynamics Ceases Operations In Russia; Announces Office In Zug, Switzerland
Grid Dynamics expands to a new European hub with an office in Zug, Switzerland
Grid Dynamics opens a new engineering office in the fast-growing tech market of Yerevan, Armenia
Grid Dynamics ceases operations in the
